Psychological intervention for negative emotion and quality of life of patients with head and neck cancer (HNC): a meta-analysis

doi:10.19439/j.sjos.2022.03.022

Abstract

Abstract: PURPOSE: To systematically assess the efficacy of psychological intervention for patients with head and neck cancer (HNC) in easing negative emotion and improving quality of life, so as to provide evidence-based reference for clinical psycho-intervention of HNC patients. METHODS: PubMed, Central, Embase, clinicaltrials.gov, ICTRP, Web of science, CBM, CNKI, VIP, and Wan Fang database were searched from inception to 15th, May for randomized controlled trails conducted to assess psychological intervention for HNC patients. The retrieval, screening, quality evaluation, and data extraction were elaborately proceeded by two reviewers independently. Meta analysis was performed using RevMan 5.4 software. RESULTS: Eighteen RCTs were included with 2 097 participants. Meta analysis showed that compared to control group, psychological intervention group manifested greater decrease in anxiety scores [SMD=-2.33, 95%CI（-2.96,-1.70）, P<0.000 01] and depression scores [SMD=-2.26, 95%CI（-2.78,-1.74）, P<0.000 01], and better increase in QOL scores [SMD=6.04, 95%CI（1.53,10.56）, P=0.009] and SQL-90 scores [MD=29.99, 95%CI（-36.22, -23.76）,P<0.000 01]. CONCLUSIONS: The anxiety and depression of HNC patients can be effectively relieved through psychological intervention, so that their quality of life and metal health status can be improved. Due to the limitation of quality of included RCT , the result remains to be further validated by more well-designed and better-qualified study.

Key words: Psychological intervention, Head and neck cancer, Negative emotion, Quality of life, Meta analysis

CLC Number:

R739.8

XIA Jia-lin, ZENG Yi-wei, ZHAO Xiao-mei, HOU Li-li. Psychological intervention for negative emotion and quality of life of patients with head and neck cancer (HNC): a meta-analysis[J]. Shanghai Journal of Stomatology, 2022, 31(3): 330-336.

References

[1] 周长波, 吕春雷. 头颈部肿瘤综合治疗的新进展[J]. 实用医药志, 2011, 28(10): 933-936.
[2] Fitzmaurice C, Allen C, Barber R, et al.Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study[J]. JAMA Oncol, 2017, 3(4): 524-548.
[3] Semple C, Dunwoody L, George KW, et al.Changes and challenges to patients' lifestyle patterns following treatment for head and neck cancer[J]. J Adv Nurs, 2008, 63(1): 85-93.
[4] Ringash J, Bernstein L, Devins G, et al.Head and neck cancer survivorship: learning the needs, meeting the needs[J]. Semin Radiat Oncol, 2018, 28(1): 64-74.
[5] Lo Nigro C, Denaro N, Merlotti A, et al.Head and neck cancer: improving outcomes with a multidisciplinary approach[J]. Cancer Manag Res, 2017, 9: 363-371.
[6] Ganzer H, Touger-Decker R, Parrott JS, et al.Symptom burden in head and neck cancer: impact upon oral energy and protein intake[J]. Support Care Cancer, 2013, 21(2): 495-503.
[7] Shiraz F, Rahtz E, Bhui K, et al.Quality of life, psychological wellbeing and treatment needs of trauma and head and neck cancer patients[J]. Br J Oral Maxillofac Surg, 2014, 52(6): 513-517.
[8] Smith JD, Shuman AG, Riba MB.Psychosocial issues in patients with head and neck cancer: an updated review with a focus on clinical interventions[J]. Curr Psychiatry Rep, 2017, 19(9): 56-66.
[9] Semple C, Parahoo K, Norman A, et al. Psychosocial interventions for patients with head and neck cancer[J]. Cochrane Database Syst Rev, 2013, (7): CD009441.
[10] Humphris G.Psychological management for head and neck cancer patients: United Kingdom National Multidisciplinary Guidelines[J]. J Laryngol Otol, 2016, 130(S2): S45-S48.
[11] Higgins JP, Altman DG, Gφtzsche PC, et al.The Cochrane Collaboration's tool for assessing risk of bias in randomised trials[J]. BMJ, 2011, 343: d5928.
[12] 崔琴琴. 强化心理干预的系统护理模式对甲状腺癌患者围手术期负性情绪的影响[J].中国妇幼健康研究, 2017, 28(S3): 317-317.
[13] 翟和平, 程哲, 朱智玲.心理干预对鼻咽癌患者心理健康状况及生活质量的影响[J].职业与健康, 2013, 29(16): 2035-2037.
[14] 董旭卉, 周吉雅.心理护理干预模式对食管癌患者生命体征及焦虑程度的影响[J]. 世界华人消化杂志, 2014, 22(28): 4321-4324.
[15] 杜碧丽, 孟歌, 陈菊.FTS结合坚强概念心理干预对食管癌患者心理健康、希望水平及癌因性疲乏的影响[J].中国健康心理学杂志, 2020, 28(5): 708-711.
[16] 黄迎春, 陆秋云, 石云华, 等.心理干预在减轻头颈肿瘤放疗患者抑郁与焦虑中的作用[J].华夏医学, 2014, 27(2): 77-79.
[17] 惠晓颖, 何爱莲. 心理痛苦分层化管理对头颈部肿瘤放化疗患者的干预研究[J].黑龙江医学, 2021, 45(2): 152-153, 157.
[18] 李佳宁, 唐宏宇, 傅宏亮.结构式团体心理治疗对甲状腺癌放射性核素治疗患者生命质量和情绪的影响[J].中国健康心理学杂志, 2009, 17(2): 243-245.
[19] 李绵, 王玉强, 齐增平, 等.心理干预对中晚期食管癌同期放化疗患者抑郁焦虑及生活质量影响[J].预防医学情报杂志, 2018, 34(9): 1131-1135.
[20] 李彦丽, 黄雪飞, 毛翔, 等.甲状腺癌手术患者实施术前心理干预护理的效果[J].国际精神病学杂志, 2019, 46(3): 558-560.
[21] 刘文慧, 吴洁. 探讨阶梯式心理护理对头颈肿瘤患者焦虑与抑郁情绪和生活质量的影响[J]. 实用临床护理学电子杂志, 2020, 5(15) :91.
[22] 刘雅清, 骆惠玉, 柯熹, 等.联合心理行为干预对鼻咽癌患者负性心理的影响[J].护理研究, 2016, 30(13): 1641-1643.
[23] 汤小丽, 文丽, 王礼芹.围手术期心理干预对喉癌患者负性情绪的影响[J].中国肿瘤临床与康复, 2015, 22(4): 477-479.
[24] 汪大祝, 赵芬, 汤宏芝.心理干预对甲状腺癌患者焦虑及抑郁症状的效果评价[J].皖南医学院学报, 2010, 29(3): 234-236.
[25] 余丽亚, 吴新正, 朱娟娟, 等.心理干预对鼻咽癌患者放疗后精神症状及生活质量的影响[J]. 中国中西医结合耳鼻咽喉科杂志, 2013, 21(1): 52-54.
[26] 朱宝燕, 李晗宁.甲状腺癌患者实施心理护理干预对其焦虑及抑郁程度的影响[J].中国药物与临床, 2017, 17(12): 1869-1871.
[27] 朱俊玲, 吴军.针对性心理干预对难治性甲状腺癌靶向性治疗患者焦虑抑郁和生活质量的影响[J].中国医药导报, 2020, 17(28): 165-168.
[28] 祝建红. 阶梯式心理护理对头颈肿瘤患者焦虑抑郁状况与生活质量的影响[J]. 心理月刊, 2021, 16(5): 205-206.
[29] Li X, Li J, Shi Y, et al.Psychological intervention improves life quality of patients with laryngeal cancer[J]. Patient Prefer Adherence, 2017, 11: 1723-1727.
[30] 王伟, 马鑫, 南亚昀, 等.心理干预对晚期肿瘤患者负性情绪影响的meta分析[J].海南医学, 2021, 32(7): 936-939.
[31] 廖巧玲, 李小麟.心理干预对胃肠道恶性肿瘤患者负性情绪及生活质量影响的meta分析[J].华南预防医学, 2019, 45(5): 428-431,485.
[32] 周晓梅, 倪杰, 陆雁.临床心理护理程序对食管癌放射治疗患者生活质量的影响[J]. 中华护理杂志, 2012, 47(11): 1028-1031.
[33] 徐征华, 田丽, 宫玺. 心理干预对老年慢性阻塞性肺疾病患者负性情绪及生活质量影响的meta分析[J]. 护理研究, 2021,35(6): 1008-1015.
[34] 尚星辰, 林征, 罗丹, 等.积极心理干预在炎症性肠病患者中应用的系统评价[J].护理研究, 2018, 32(20): 3229-3235.
[35] 周凯娜, 李津, 李小妹.乳腺癌术后病人健康相关生活质量心理干预效果系统评价[J].护理研究, 2016, 30(10): 3739-3743.
[36] Niedzwiedz CL, Knifton L, Robb KA, et al.Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority[J]. BMC Cancer, 2019, 19(1): 943-950.